Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Arcellx, Inc. - Common Stock (NQ: ACLX )

36.45 +1.49 (+4.26%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 557,315
Open 35.01
Bid (Size) 34.49 (1)
Ask (Size) 36.70 (1)
Prev. Close 34.96
Today's Range 34.63 - 36.49
52wk Range 16.97 - 45.04
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analysts Stay Bullish On Arcellx's CART-ddBCMA's Long-term Therapeutic Potential
The FDA lifted the partial clinical hold on Arcellx Inc's (NASDAQ: ACLX) iMMagine-1 Phase 2 Clinical Program. 
Via Benzinga
Exposures Product Safety
FDA Gives Green Signal To Arcellx's Stopped Blood Cancer Study
The FDA lifted the partial clinical hold on Arcellx Inc's (NASDAQ: ACLX) iMMagine-1 Phase 2  
Via Benzinga
Exposures Product Safety

Performance

YTD
+17.47%
+17.47%
1 Month
+1.59%
+1.59%
3 Month
+15.64%
+15.64%
6 Month
+17.24%
+17.24%
1 Year
+92.86%
+92.86%

More News

Read More
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Analyst Ratings for Arcellx
Via Benzinga
Arcellx, A Top 5% Biotech, Dives After A 'Perfect Storm' Leads To A Patient's Death
Via Investor's Business Daily
Why Arcellx (ACLX) Stock Is Nosediving
Via Benzinga
The Latest Analyst Ratings for Arcellx
Via Benzinga
Where Arcellx Stands With Analysts
Via Benzinga
What 5 Analyst Ratings Have To Say About Arcellx
Via Benzinga
Where Arcellx Stands With Analysts
Via Benzinga
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Arcellx's Lead Product Candidate Hit By FDA Clinical Hold For Multiple Myeloma, Stock Falls
Via Benzinga
Why Cano Health Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Alibaba, Arcellx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 13, 2023
Via Benzinga
Kite and Arcellx Close Agreement to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma
From Gilead Sciences, Inc. and Arcellx, Inc.
Via Business Wire
20 Favorite Biotech & Medical Stocks For 2023
Via Talk Markets
Dow Tumbles 100 Points; Silver Rises Over 2%
Via Benzinga
US Stocks Turn Higher; Nasdaq Rises 40 Points
Via Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.